Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Zhongzhao Wang
Pretreatment Systemic Inflammation Response Index in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
Cancer Management and Research
Oncology
Related publications
CD44v9 as a Poor Prognostic Factor of Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy
Breast Cancer
Nuclear Medicine
Radiology
Pharmacology
Oncology
Imaging
Medicine
Association of Pretreatment Anemia With Pathological Response and Survival of Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Population-Based Study
PLoS ONE
Multidisciplinary
Epigenetic Changes Associated With Inflammation in Breast Cancer Patients Treated With Chemotherapy
Brain, Behavior, and Immunity
Endocrine
Immunology
Behavioral Neuroscience
Autonomic Systems
Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Prognostic Value of Preoperative Systemic Immune-Inflammation Index in Patients With Cervical Cancer
Scientific Reports
Multidisciplinary
Evaluation of Prognostic Factors and Validation of Tumor Response Ratios After Neoadjuvant Chemotherapy in Patients With Breast Cancer
Journal of Breast Disease
Predictors of Recurrence in Breast Cancer Patients With a Pathologic Complete Response After Neoadjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
Long-Term Prognostic and Predictive Factors in 107 Stage II/III Breast Cancer Patients Treated With Anthracycline-Based Neoadjuvant Chemotherapy
British Journal of Cancer
Cancer Research
Oncology
ERCC1 Codon 118 Polymorphism Is a Useful Prognostic Marker in Patients With Pancreatic Cancer Treated With Platinum-Based Chemotherapy
International Journal of Oncology
Cancer Research
Oncology
